Senior Scientist, Pre-clinical NGS

Why Join Intellia?

Our mission is to develop curative genome editing treatments that can positively transform the lives of people living with severe and life-threatening diseases.

Beyond our science, we live our four core values: One, Explore, Disrupt, Deliver and feel strongly that you can achieve more at Intellia. We have a single-minded determination to excel and succeed together. We believe in the power of curiosity and pushing boundaries. We welcome challenging thoughts and imagination to develop innovative solutions. And we know that patients are counting on us to make the promise a reality, so we must maintain high standards and get it done.

We wantall ofour people to go beyond what is possible. We aren’t constrained by typical end rails, and we aren’t out to just “treat” people. We’re all in this for something more. We’re driven to cure and motivated for change. Just imagine the possibilities of what we can do together.

​How you will Achieve More with Intellia:

​​​Intellia is look for a Senior Scientist focused on NGS to support the advancement of genome editing products into the clinic. Within this leadership role you will be responsible for implementation and execution of on target and genotoxicity data packages enabling in vivo and cell therapy program progression into clinical trials. You will be responsible for the documentation enabling regulatory filings including data documentation and quality control. In this leadership position you will serve on therapeutic program teams supporting regulatory filings and documentation. In this role you will:​

• ​Execute on genotoxicity data packages in support of regulatory filings and clinical programs

• ​Transition genomic assays from research into development through optimization and validation to apply to regulatory programs implementing SOPs, standards, etc

• ​Ensure data quality and writing of technical reports, genotoxicity addendums, briefing books, INDs, CTAs and other requests from global regulatory authorities

• ​Partner with computational biology, software engineering, and PreClinical Project Management on data analysis, data capture, and documentation

• ​Partner with Genomic Innovation to develop and align on off target and genomic characterization assays to support pipeline programs and platform technology

• ​Serve as SME for genotoxicity assessment in support of in vivo and cell therapy development program advancement to the clinic

• ​Partner with PreClinical in vitro pharmacology on strategy for in vitro sample preparation in support of genotoxicity assays

• ​Effectively interact with other functional area experts in a program team environment to execute on the best course of action for genotoxicity assessment

• ​Partner with Toxicology on strategy and guidance for genotoxicity assessment for gene editing approaches

• ​Work with PreClinical Project Management to align resources and timelines

• ​Partner with regulatory, clinical, and program team leads to support regulatory filings

• ​Coach and mentor junior level scientist

​​​

​About You:​

​​The Senior Scientist NGS will have demonstrated expertise and in NGS and other sequencing methodologies, molecular biology, gene editing approaches, experience in supporting gene editing therapies into the clinic including engaging with health authorities both written and verbally.

• ​PhD with 2-6 years directly related industry experience or BS/MS 8-14 year equivalent relevant experience

• ​Solid hands-on experience in DNA/RNA sequencing library preparation, quantification, and sequencing using Illumina sequencing platforms (NextSeq, Miseq, NovaSeq).

• ​Extensive knowledge of CRISPR gene editing approaches and genotoxicity assays.

• ​Experience with liquid handling platforms (preferably Hamilton) is preferred.

• ​Experience in writing and documentation to support regulatory filings as well as response to health authority questions and interacting with health authorities.​

​

​Meet your future team:

​

​​You will be an SME for genotoxicity and gene editing products working closely with PreClinical in vitro pharmacology, Computational Biology, Toxicology, Genomics Innovation and PreClinical Project Management to support the development of genome editing based therapeutics into the clinic. We are accountable for enabling our programs in early research to reach development candidate nomination through regulatory filing and into clinical trials.

​

​In this key leadership role, you will report directly to the Head of Preclinical Genomics, who instills a culture of teamwork, respect, inclusion, collaboration, and communication ensuring that each team member strives to reach their professional and personal potential.​

LI-KO1

Covid-19 Vaccination Policy: All Intellia employees, regardless of work location, must be fully vaccinated for COVID-19. This requirement includes a booster dose once eligible. Requests for exemption for medical or sincerely held religious beliefs will be considered.

EEOC Statement: Intellia believes in a diverse environment, and is committed to equal employment opportunity for all its employees and qualified applicants. We do not discriminate in recruitment, hiring, training, promotion or any other employment practices for reasons of race, color, religion, gender, national origin, age, sexual orientation, marital or veteran status, disability, or any other legally protected status. Intellia will make reasonable accommodations for qualified individuals with known disabilities, in accordance with applicable law.